| Revenue growth | 33% YoY growth in revenue from operations for Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 28.6%; ARPOB up 6% to INR 67,256. |
| Demand visibility | High; IP discharges and OP consultations grew 28% and 25% respectively. |
| Management confidence | Strong; expanding footprint into 9 cities with 24 hospitals. |
Growth
Revenue grew 33% YoY to INR 4,700 Mn; PAT increased 16% YoY to INR 625.4 Mn. IP discharges up 28%.
Outlook
Targeting 3,725 total beds by FY29. New hospitals planned in Coimbatore, Gurugram, Andhra Pradesh, and Maharashtra.
Risks
EBITDA margin slightly compressed from 29.4% to 28.6% YoY. Higher professional fees to doctors (up 35%).
Last quarter's promises, checked
Delivered
- Guided 20% revenue growth → delivered 33% (= BEAT)
- Guided ~20% IP volume growth → delivered 28% (= BEAT)
- Guided 56-57% blended occupancy → delivered 34.4-45% (= MISS)
Partly delivered
- Guided 900+ beds in execution → delivered 130% capacity growth in new units (= PARTIAL)
Missed
- Guided maintaining margins → delivered 28.6% vs 32% previous (= MISS)
Investor Presentation filed with NSE, NSE: RAINBOW. Summary written with AI assistance from the document.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,284.50
- Market cap
- ₹13,046 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 44.6×Sector 54.5×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Earnings Call Transcript: Key Takeaways
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
- Call
- Guides 18% growth
Rainbow Childrens Medicare Results Update
Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.
- hospital beds
- 120.0 beds
Rainbow Childrens Medicare Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹548 Cr (+23% YoY) and PAT ₹84 Cr (+11%). Post-IndAS EBITDA margin fell to 31.0% from 33.5%. Strategy is hub-and-spoke pediatric and maternity expansion across 26 hospitals.
Rainbow Childrens Medicare Q2 FY27 Results: Net Profit ₹83.9 Cr, Up 11.0% YoY
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹548 Cr (+23.2% YoY) and net profit of ₹83.9 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹83.9 Cr · +11.0% YoY
Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.